A Aralex Aachen research explorer

Gerjan de Bruin Sign in to save

OpenAlex Aachen author

Currently: Acerta Pharma BV (Netherlands)

1.38k

Citations

22

h-index

26

i10-index

46

Works (all)

1

Aachen papers

Departments & institutes in Aachen

Department of Chemical Biology Leiden University

1 paper · 2024
Leiden Institute of Chemistry, the Netherlands Leiden University

1 paper · 2024

Affiliations exactly as printed on papers (1)

1× Department of Chemical Biology, Leiden Institute of Chemistry, the Netherlands (G.d.B., B.I.F.)

Papers 1 stored

All · Aachen affiliation only

Immunoproteasomal Inhibition With ONX-0914 Attenuates Atherosclerosis and Reduces White Adipose Tissue Mass and Metabolic Syndrome in Mice
2024 Arteriosclerosis Thrombosis and Vascular Biology article Immunology and Microbiology Atherosclerosis and Cardiovascular Diseases Open access

10

citations

1 result

Affiliation history

AstraZeneca (United States) US · 2022
Acerta Pharma BV (Netherlands) NL · 2018–2025
Leiden University Medical Center NL · 2016
Leiden University NL · 2013–2024
The Netherlands Cancer Institute NL · 2013
Netherlands Proteomics Centre NL · 2013–2019
Utrecht University NL · 2012

Line of work

Ubiquitin and proteasome pathways 27

Biochemistry, Genetics and Molecular Biology › Molecular Biology
Protein Degradation and Inhibitors 20

Biochemistry, Genetics and Molecular Biology › Molecular Biology
Protease and Inhibitor Mechanisms 17

Biochemistry, Genetics and Molecular Biology › Cancer Research
Chronic Lymphocytic Leukemia Research 9

Medicine › Genetics
Lymphoma Diagnosis and Treatment 8

Medicine › Pathology and Forensic Medicine

Citations per year

12

13

14

15

16

17

18

19

20

22

23

24

25

Institutions on Aachen-era papers

Leiden University 1

Similar authors in Aachen

Loading…

Co-author network

Loading…

Frequent co-authors

Profile fetched: 09 Oct 00:00